Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The use of nanoparticles in medical applications is highly anticipated, and at the same time little is known about how these nanoparticles affect human tissues. Here we have simulated the oral uptake of 50 nm carboxylated polystyrene nanoparticles with a microscale body-on-a-chip system (also referred to as multi-tissue microphysiological system or micro Cell Culture Analog). Using the 'GI tract-liver-other tissues' system allowed us to observe compounding effects and detect liver tissue injury at lower nanoparticle concentrations than was expected from experiments with single tissues. To construct this system, we combined in vitro models of the human intestinal epithelium, represented by a co-culture of enterocytes (Caco-2) and mucin-producing cells (TH29-MTX), and the liver, represented by HepG2/C3A cells, within one microfluidic device. The device also contained chambers that together represented the liquid portions of all other organs of the human body. Measuring the transport of 50 nm carboxylated polystyrene nanoparticles across the Caco-2/HT29-MTX co-culture, we found that this multi-cell layer presents an effective barrier to 90.5 ± 2.9% of the nanoparticles. Further, our simulation suggests that a larger fraction of the 9.5 ± 2.9% nanoparticles that travelled across the Caco-2/HT29-MTX cell layer were not large nanoparticle aggregates, but primarily single nanoparticles and small aggregates. After crossing the GI tract epithelium, nanoparticles that were administered in high doses estimated in terms of possible daily human consumption (240 and 480 × 10(11) nanoparticles mL(-1)) induced the release of aspartate aminotransferase (AST), an intracellular enzyme of the liver that indicates liver cell injury. Our results indicate that body-on-a-chip devices are highly relevant in vitro models for evaluating nanoparticle interactions with human tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“At the same time, they overcame the inaccessibility of cystic organoids and clearance of cell debris by creating a perfusable culture of mini-intestines where cells are arranged to form tube-shaped epithelia and similar spatial arrangement as the in vivo tissue100.”
From Organoids (2022) · cites this paper as [100]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“creation of Intestine Chips can facilitate study of drug breakdown both alone and when coupled to other Organ Chips that also contribute to drug metabolism (eg, Liver Chip) and clearance (eg, Kidney Chip) in a human Body-on-a-Chip configuration.36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pooling together different cells and/or organoids for bulk analysis can lead to inaccurate results3,70,100,204,207,208.”
From Organoids (2022) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some devices integrated multiple chambers with different types of cells to measure PK and pharmacodynamics (PD) properties of drug compounds in vitro.35, 36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Tzima, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4639 · Cited by 569
A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters
Ramaiah, S. K. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.007 · Cited by 494
Revisiting lab-on-a-chip technology for drug discovery
Neužil, P., Giselbrecht, S., Länge, K., Huang, T. J., & Manz, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3799 · Cited by 487
Nanoparticle-induced surface reconstruction of phospholipid membranes
Wang, B., Zhang, L., Bae, S. C., & Granick, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807296105 · Cited by 469
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Oral exposure to polystyrene nanoparticles affects iron absorption
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.3 · Cited by 340
The Role of Body-on-a-Chip Devices in Drug and Toxicity Studies
Esch, M. B., King, T. L., & Shuler, M. L. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124629 · Cited by 328
Mahler, G. J., Shuler, M. L., & Glahn, R. P. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.05.006 · Cited by 287
In vitro and in vivo models for the study of oral delivery of nanoparticles
Gamboa, J. M., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.003 · Cited by 285
Service, R. F. (2004) · Science · doi:10.1126/science.304.5678.1732 · Cited by 285
Nano hemostat solution: immediate hemostasis at the nanoscale
Ellis-Behnke, R. G., Liang, Y.-X., Tay, D. K. C., Kau, P. W. F., Schneider, G. E., Zhang, S., Wu, W., & So, K.-F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.08.001 · Cited by 269
Modeling Interindividual Variation in Physiological Factors Used in PBPK Models of Humans
Price, P. S., Conolly, R. B., Chaisson, C. F., Gross, E. A., Young, J. S., Mathis, E. T., & Tedder, D. R. (2003) · Critical Reviews in Toxicology · doi:10.1080/10408440390242324 · Cited by 239
Mahler, G. J., Esch, M. B., Glahn, R. P., & Shuler, M. L. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22366 · Cited by 221
van Midwoud, P. M., Merema, M. T., Verpoorte, E., & Groothuis, G. M. M. (2010) · Lab on a Chip · doi:10.1039/c0lc00043d · Cited by 203
Baker, M. (2011) · Nature · doi:10.1038/471661a · Cited by 188
Comparative, Quantitative Study of Lymphoid and Non-Lymphoid Uptake of 60 nm Polystyrene Particles
Hillery, A., Jani, P., & Florence, A. (1994) · Journal of Drug Targeting · doi:10.3109/10611869409015904 · Cited by 169
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model
Ingels, F., Deferme, S., Destexhe, E., Oth, M., Van den Mooter, G., & Augustijns, P. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00897-3 · Cited by 166
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Shakweh, M., Ponchel, G., & Fattal, E. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.141 · Cited by 159
Kaida, S., Cabral, H., Kumagai, M., Kishimura, A., Terada, Y., Sekino, M., Aoki, I., Nishiyama, N., Tani, T., & Kataoka, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0303 · Cited by 135
Enomoto, N., Yamashina, S., Kono, H., Schemmer, P., Rivera, C. A., Enomoto, A., Nishiura, T., Nishimura, T., Brenner, D. A., & Thurman, R. G. (1999) · Hepatology · doi:10.1002/hep.510290633 · Cited by 132
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Single walled carbon nanotubes for transport and delivery of biological cargos
Kam, N. W. S., & Dai, H. (2006) · physica status solidi (b) · doi:10.1002/pssb.200669226 · Cited by 100
Russell-Jones, G. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00127-7 · Cited by 77
Characterization of In Vitro Endothelial Linings Grown Within Microfluidic Channels
Esch, M. B., Post, D. J., Shuler, M. L., & Stokol, T. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0371 · Cited by 74
Use of Simulated Intestinal Fluids with Caco-2 Cells and Rat Ileum
Patel, N., Forbes, B., Eskola, S. M., & Murray, J. M. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500465991 · Cited by 65
Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling
Sung, J. H., Esch, M. B., & Shuler, M. L. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.496251 · Cited by 64
Choi, S. H., Nishikawa, M., Sakoda, A., & Sakai, Y. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2003.09.010 · Cited by 59
Mucoadhesion of Latexes. II. Adsorption Isotherms and Desorption Studies
Durrer, C., Irache, J. M., Puisieux, F., Duchêne, D., & Ponchel, G. (1994) · Pharmaceutical Research · doi:10.1023/a:1018920128007 · Cited by 53
Choi, S. H., Fukuda, O., Sakoda, A., & Sakai, Y. (2004) · Materials Science and Engineering C · doi:10.1016/j.msec.2003.12.002 · Cited by 42
Mucoadhesion of Latexes. I. Analytical Methods and Kinetic Studies
Durrer, C., Irache, J. M., Puisieux, F., Duchêne, D., & Ponchel, G. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968011169 · Cited by 41
Gene Response in Endothelial Cells Cultured on Engineered Surfaces Is Regulated by Shear Stress
Fernandez, P., Bourget, C., Bareille, R., Daculsi, R., & Bordenave, L. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0399 · Cited by 31
Khamsi, R. (2005) · Nature · doi:10.1038/435012a · Cited by 30
Leveraging Shear Stress to Bust Clots with Nanoparticles
Lavik, E., & Ustin, J. (2012) · Science · doi:10.1126/science.1227097 · Cited by 12
Research works printed but not linked: 1
- Neui P Giselbrecht S Lange K Huang TJ Manz A Nature Reviews Drug Discovery 2012 11 620 632 22850786 PMC6493334
Cited by
TEER Measurement Techniques for In Vitro Barrier Model Systems
Srinivasan, B., Kolli, A. R., Esch, M. B., Abaci, H. E., Shuler, M. L., & Hickman, J. J. (2015) · SLAS Technology · doi:10.1177/2211068214561025 · Cited by 2,145
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,082
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Xuan, L., Ju, Z., Skonieczna, M., Zhou, P., & Huang, R. (2023) · MedComm · doi:10.1002/mco2.327 · Cited by 807
Metadata
- Authors
- Esch, M. B., Mahler, G. J., Stokol, T., & Shuler, M. L.
- Affiliations
- Cornell University (US)
- Binghamton University (US)
- Corresponding author
- Shuler, Michael L.
- Venue
- Lab Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 14
- Issue
- 16
- Pages
- 3081-3092
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC4144667
- OpenAlex
- W2030338281
- Cited by
- 281
- References
- 37
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 16 · 2023: 30 · 2022: 20 · 2021: 27 · 2020: 23 · 2019: 28 · 2018: 30 · 2017: 25 · 2016: 31 · 2015: 12 · 2014: 4
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (UH2TR000516)
- National Center for Advancing Translational Sciences
- U.S. Army Corps of Engineers
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- body-on-a-chip, organ-on-a-chip, gastrointestinal tract, liver injury, Caco-2/HT29-MTX co-culture, intestinal epithelial barrier, nanoparticle transport, nanoparticle aggregation, nanoparticle toxicity
- MeSH terms
- Analysis of Variance, Cell Line, Cell Survival, Humans, Intestinal Mucosa, Liver, Models, Biological, Toxicity Tests, Cell Culture Techniques, Gastrointestinal Tract, Microfluidic Analytical Techniques, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.